Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study.

Cioni M, Nocera A, Tagliamacco A, Basso S, Innocente A, Fontana I, Magnasco A, Trivelli A, Klersy C, Gurrado A, Ramondetta M, Boghen S, Catenacci L, Verrina E, Garibotto G, Ghiggeri GM, Cardillo M, Ginevri F, Comoli P.

Transpl Int. 2019 Jan;32(1):38-48. doi: 10.1111/tri.13325. Epub 2018 Aug 27.

PMID:
30076765
2.

De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients.

Cioni M, Nocera A, Innocente A, Tagliamacco A, Trivelli A, Basso S, Quartuccio G, Fontana I, Magnasco A, Drago F, Gurrado A, Guido I, Compagno F, Garibotto G, Klersy C, Verrina E, Ghiggeri GM, Cardillo M, Comoli P, Ginevri F.

J Immunol Res. 2017;2017:1747030. doi: 10.1155/2017/1747030. Epub 2017 Mar 6.

3.

Acquisition of C3d-Binding Activity by De Novo Donor-Specific HLA Antibodies Correlates With Graft Loss in Nonsensitized Pediatric Kidney Recipients.

Comoli P, Cioni M, Tagliamacco A, Quartuccio G, Innocente A, Fontana I, Trivelli A, Magnasco A, Nocco A, Klersy C, Rubert L, Ramondetta M, Zecca M, Garibotto G, Ghiggeri GM, Cardillo M, Nocera A, Ginevri F.

Am J Transplant. 2016 Jul;16(7):2106-16. doi: 10.1111/ajt.13700. Epub 2016 Feb 16.

4.

Posttransplant soluble B-cell activating factor kinetics in pediatric recipients of first kidney allograft.

Comoli P, Quartuccio G, Cioni M, Parodi A, Nocera A, Basso S, Fontana I, Magnasco A, Sioli V, Guido I, Klersy C, Zecca M, Cardillo M, Ghiggeri GM, Ginevri F.

Transplantation. 2015 Jan;99(1):243-9. doi: 10.1097/TP.0000000000000276.

PMID:
25033258
5.

DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.

Tagliamacco A, Cioni M, Comoli P, Ramondetta M, Brambilla C, Trivelli A, Magnasco A, Biticchi R, Fontana I, Dulbecco P, Palombo D, Klersy C, Ghiggeri GM, Ginevri F, Cardillo M, Nocera A.

Transpl Int. 2014 Jul;27(7):667-73. doi: 10.1111/tri.12316. Epub 2014 Apr 25.

6.

Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.

Ravani P, Ponticelli A, Siciliano C, Fornoni A, Magnasco A, Sica F, Bodria M, Caridi G, Wei C, Belingheri M, Ghio L, Merscher-Gomez S, Edefonti A, Pasini A, Montini G, Murtas C, Wang X, Muruve D, Vaglio A, Martorana D, Pani A, Scolari F, Reiser J, Ghiggeri GM.

Kidney Int. 2013 Nov;84(5):1025-33. doi: 10.1038/ki.2013.211. Epub 2013 Jun 5.

7.

Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.

Ginevri F, Nocera A, Comoli P, Innocente A, Cioni M, Parodi A, Fontana I, Magnasco A, Nocco A, Tagliamacco A, Sementa A, Ceriolo P, Ghio L, Zecca M, Cardillo M, Garibotto G, Ghiggeri GM, Poli F.

Am J Transplant. 2012 Dec;12(12):3355-62. doi: 10.1111/j.1600-6143.2012.04251.x. Epub 2012 Sep 7.

8.

Rituximab in children with resistant idiopathic nephrotic syndrome.

Magnasco A, Ravani P, Edefonti A, Murer L, Ghio L, Belingheri M, Benetti E, Murtas C, Messina G, Massella L, Porcellini MG, Montagna M, Regazzi M, Scolari F, Ghiggeri GM.

J Am Soc Nephrol. 2012 Jun;23(6):1117-24. doi: 10.1681/ASN.2011080775. Epub 2012 May 10.

9.

Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.

Ravani P, Magnasco A, Edefonti A, Murer L, Rossi R, Ghio L, Benetti E, Scozzola F, Pasini A, Dallera N, Sica F, Belingheri M, Scolari F, Ghiggeri GM.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1308-15. doi: 10.2215/CJN.09421010. Epub 2011 May 12.

10.

Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephrotic syndrome.

Bertelli R, Trivelli A, Magnasco A, Cioni M, Bodria M, Carrea A, Montobbio G, Barbano G, Ghiggeri GM.

Clin Exp Immunol. 2010 Jul 1;161(1):151-8. doi: 10.1111/j.1365-2249.2010.04160.x. Epub 2010 May 19.

11.

Nephrectomy for multicystic dysplastic kidney and renal hypodysplasia in children: where do we stand?

Mattioli G, Pini-Prato A, Costanzo S, Avanzini S, Rossi V, Basile A, Ghiggeri GM, Magnasco A, Leggio S, Rapuzzi G, Jasonni V.

Pediatr Surg Int. 2010 May;26(5):523-8. doi: 10.1007/s00383-010-2592-7. Epub 2010 Mar 26.

PMID:
20339852
12.

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

Prunotto M, Carnevali ML, Candiano G, Murtas C, Bruschi M, Corradini E, Trivelli A, Magnasco A, Petretto A, Santucci L, Mattei S, Gatti R, Scolari F, Kador P, Allegri L, Ghiggeri GM.

J Am Soc Nephrol. 2010 Mar;21(3):507-19. doi: 10.1681/ASN.2008121259. Epub 2010 Feb 11.

13.

Two cases of swine H1N1 influenza presenting with hematuria as prodrome.

Ghiggeri GM, Losurdo G, Ansaldi F, Canepa A, Magnasco A.

Pediatr Nephrol. 2010 Apr;25(4):779-80. doi: 10.1007/s00467-009-1380-x. Epub 2009 Dec 2. No abstract available.

PMID:
19953274
14.

Mesenchymal stem cells protective effect in adriamycin model of nephropathy.

Magnasco A, Corselli M, Bertelli R, Ibatici A, Peresi M, Gaggero G, Cappiello V, Chiavarina B, Mattioli G, Gusmano R, Ravetti JL, Frassoni F, Ghiggeri GM.

Cell Transplant. 2008;17(10-11):1157-67.

PMID:
19181210
15.

Cyclosporin and organ specific toxicity: clinical aspects, pharmacogenetics and perspectives.

Magnasco A, Rossi A, Catarsi P, Gusmano R, Ginevri F, Perfumo F, Ghiggeri GM.

Curr Clin Pharmacol. 2008 Sep;3(3):166-73. Review.

PMID:
18781903
16.

GIT (Glucose Infusion Test): polycentric evaluation of a new test for vascular access recirculation.

Alloatti S, Magnasco A, Bonfant G, Bonello F, Ciciani AM, Fidelio T, Filiberti O, Forneris G, Martina G, Robaudo C, Romano U, Schelotto C.

J Vasc Access. 2000 Oct-Dec;1(4):152-7.

PMID:
17638247
17.

Glucose infusion test (GIT) compared with the saline dilution technology in recirculation measurements.

Magnasco A, Alloatti S.

Nephrol Dial Transplant. 2006 Nov;21(11):3180-4. Epub 2006 Aug 5.

PMID:
16891645
18.

Pre-dialysis application of the glucose infusion test for recirculation detection.

Libori C, Spallazzi M, Bono M, Brozzo C, Celsi M, Grisanti S, Iaria B, Pellegrotti D, Pensierini D, Magnasco A.

EDTNA ERCA J. 2005 Oct-Dec;31(4):191-3.

PMID:
16551023
19.

Thresholds for significant decrease in hemodialysis access blood flow.

Ram SJ, Nassar R, Sharaf R, Magnasco A, Jones SA, Paulson WD.

Semin Dial. 2005 Nov-Dec;18(6):558-64.

PMID:
16398721
20.

Efficacy prospective study of different frequencies of Epo administration by i.v. and s.c. routes in renal replacement therapy patients.

Messa P, Nicolini MA, Cesana B, Brezzi B, Zattera T, Magnasco A, Moroni G, Campise M.

Nephrol Dial Transplant. 2006 Feb;21(2):431-6. Epub 2005 Oct 25.

PMID:
16249199
21.

[Hemodialysis access recirculation].

Alloatti S, Magnasco A, Manes M, Bonfant G.

G Ital Nefrol. 2004 Sep-Oct;21(5):438-45. Review. Italian.

PMID:
15547875
22.

Comparison of glucose pump test and urea test in measuring blood access flow.

Alloatti S, Magnasco A, Bonfant G, Pellu V, Paroli V.

J Nephrol. 2004 Jul-Aug;17(4):559-64.

PMID:
15372419
23.

Clinical validation of glucose pump test (GPT) compared with ultrasound dilution technology in arteriovenous graft surveillance.

Magnasco A, Bacchini G, Cappello A, La Milia V, Brezzi B, Messa P, Locatelli F.

Nephrol Dial Transplant. 2004 Jul;19(7):1835-41. Epub 2004 May 25.

PMID:
15161950
24.

In vivo validation of glucose pump test for measurement of hemodialysis access flow.

Ram SJ, Magnasco A, Jones SA, Barz A, Zsom L, Swamy S, Paulson WD.

Am J Kidney Dis. 2003 Oct;42(4):752-60.

PMID:
14520626
25.

Glucose pump test: a new method for blood flow measurements.

Magnasco A, Alloatti S, Martinoli C, Solari P.

Nephrol Dial Transplant. 2002 Dec;17(12):2244-8.

PMID:
12454240
26.

Glucose infusion test: a new screening test for vascular access recirculation.

Magnasco A, Alloatti S, Bonfant G, Copello F, Solari P.

Kidney Int. 2000 May;57(5):2123-8.

27.

Four year experience in laparoscopic dissection of intact ovarian dermoid cysts.

Remorgida V, Magnasco A, Pizzorno V, Anserini P.

J Am Coll Surg. 1998 Nov;187(5):519-21.

PMID:
9809569
28.

Comparison of a blocking vs. a flare-up protocol in poor responders with a normal and abnormal clomiphene citrate challenge test.

Anserini P, Magnasco A, Remorgida V, Gaggero G, Testa D, Capitanio GL.

Gynecol Endocrinol. 1997 Oct;11(5):321-6.

PMID:
9385531
29.

Microalbuminuria is associated with a worse cardiovascular risk profile and target organ damage in essential hypertension.

Pontremoli R, Sofia A, Tirotta A, Ravera M, Nicolella C, Viazzi F, Magnasco A, Del Sette M, Martinoli C, Deferrari G.

Contrib Nephrol. 1996;119:115-20. No abstract available.

PMID:
8783601
30.

Blood amino acid levels and erythropoietin treatment in hemodialysis patients.

Garibotto G, Gurreri G, Robaudo C, Saffioti S, Magnasco A, Sofia A, Marchelli M, Sala MR.

Nephron. 1995;69(2):197. No abstract available.

31.

Erythropoietin treatment and amino acid metabolism in hemodialysis patients.

Garibotto G, Gurreri G, Robaudo C, Saffioti S, Magnasco A, Sofia A, Marchelli M, Sala MR.

Nephron. 1993;65(4):533-6.

PMID:
8302405
32.

Muscle amino acid and protein metabolism in chronic renal failure.

Garibotto G, Russo R, Robaudo C, Saffioti S, Magnasco A, Deferrari G, Tizianello A.

Contrib Nephrol. 1992;98:1-10. Review. No abstract available.

PMID:
1493718
33.

Interaction of ketoconazole and ethanol.

Magnasco AJ, Magnasco LD.

Clin Pharm. 1986 Jun;5(6):522-3. No abstract available.

PMID:
2941211
34.

Metallic taste associated with tetracycline therapy.

Magnasco LD, Magnasco AJ.

Clin Pharm. 1985 Jul-Aug;4(4):455-6. No abstract available.

PMID:
4042562
35.

[Tetanic cataract. (Clinical case)].

Magnasco A, Zingirian M, Altieri G.

Ann Ottalmol Clin Ocul. 1969 Jun;95(6):527-44. Italian. No abstract available.

PMID:
5408362
36.

[On a case of manifestations of an allergic type in the course of fluorescein angiographic examinations].

Magnasco A, Trillo M.

Ann Ottalmol Clin Ocul. 1969 Jun;95(6):565-8. Italian. No abstract available.

PMID:
4250922
37.

[On the effectiveness of combined therapy with a polysulpho-ester of xylan (Fibrase) and dextran (Macrodex) in vascular occlusions of the retina].

Cambiaggi A, Magnasco A, Sanna G.

Ann Ottalmol Clin Ocul. 1968 Apr;94(4):349-55. Italian. No abstract available.

PMID:
5708189
38.

[On a rare case of rapidly developing histioid leukemia appearing after radiotherapeutic and antiblastic treatment of retinoblastoma].

Magnasco A, Zingirian M, Cottafava F.

Ann Ottalmol Clin Ocul. 1967 Mar;93(3):300-8. Italian. No abstract available.

PMID:
5606173
39.

[Influence of anthocyanosides on the mesopic differential threshold of the retina].

Magnasco A, Zingirian M.

Ann Ottalmol Clin Ocul. 1966 Mar;92(3):188-93. Italian. No abstract available.

PMID:
5959662
40.

[Unusual malformation association: mandibulo-facial dysostosis and bilateral microspherofachia].

Magnasco A, Zingirian M.

Ann Ottalmol Clin Ocul. 1965 Jun;91(6):489-96. Italian. No abstract available.

PMID:
5839955
41.

[Roentgenotherapy of inflammatory processes of the uvea].

BALESTRA E, PODESTA AM, MAGNASCO A.

Minerva Med. 1962 May 2;53:1321-3. Italian. No abstract available.

PMID:
13864359
42.

[Dimensions of the blind spot: its variations within the limits of normality and in relation to various technics of determination].

MONTALDI M, MAGNASCO A.

Ann Ottalmol Clin Ocul. 1961 Nov;87:608-20. Italian. No abstract available.

PMID:
14475460
43.

[Ocular pathology in persons over 60 years of age. (Statistical research on patients and on ambulatory cases from 1934 to 1958)].

NERVI I, MARENA F, MAGNASCO A.

Ann Ottalmol Clin Ocul. 1959 Dec;85:621-35. Italian. No abstract available.

PMID:
14426557
44.

[Ocular pathology of persons over sixty. (Statistical research on patients and on ambulatory cases from 1934 to 1958)].

NERVI I, MARENA F, MAGNASCO A.

G Gerontol Suppl. 1959;Suppl 21:76-82. Italian. No abstract available.

PMID:
14426558

Supplemental Content

Loading ...
Support Center